Leadership

  

Links

George Carpenter, President and Chief Executive Officer

George Carpenter is a results-oriented executive with a passion for leading high growth and turnaround companies. As President and Chief Executive Officer of CNS Response, Inc., George is leading the commercialization of the company’s patented Referenced-EEG technology. Before joining CNS Response Inc., George ran WorkWell Systems Inc., an international physical medicine firm and 2004 winner of the ABL Innovation in Healthcare Award. From 1990 to 2002, George served as Chairman and CEO of CORE, Inc., (Nasdaq: CORE) after leading the management buyout of this division of Baxter Healthcare. A finalist in the E&Y Entrepreneur of the Year program, Carpenter led CORE to a record of clinical software innovation and business development that, in the words of one Wall Street analyst, "created an industry". CORE was acquired in 2001 by Assurant Inc. George was a Vice President of Operations with Baxter Healthcare before founding CORE. His career began at Inland Steel in manufacturing process control and Sales. Serving on various biomedical advisory and fiduciary boards, he is a frequent speaker and writer on healthcare technology and financing issues. His book "The Shape of Things" (LRP Publications, 2006) focused on the neurochemistry of obesity and its impact on the American workforce. He holds an MBA in Finance from the University of Chicago and a BA with Distinction in International Policy & Law from Dartmouth College.

 

Daniel A. Hoffman, M.D., Chief Medical Officer

Daniel Hoffman, MD is a Neuropsychiatrist with over 25 years experience treating general psychiatric conditions such as depression, bipolar disorder and anxiety. He provides the newest advances in diagnosing and treating attentional and learning problems in children and adults. Dr. Hoffman has authored over 40 professional articles, textbook chapters, poster presentations and letters to the editors on various aspects of neuropsychiatry, Quantitative EEG, LORETA, Referenced EEG, advances in medication management, national position papers and standards, Mild Traumatic Brain Injury, neurocognitive effects of Silicone Toxicity, sexual dysfunction and other various topics. Dr. Hoffman has given over 58 major presentations and seminars, including Grand Rounds at Universities and Hospitals, workshops and presentations at national society meeting (such as American Psychiatric Association and American Neuropsychiatric Association), national CME conferences, insurance companies, national professional associations, panel member discussant, and presenter of poster sessions. Dr. Hoffman has a Bachelor of Science in Psychology from the University of Michigan, an MD from Wayne State University School of Medicine and conducted his Residency in Psychiatry from the University of Colorado Health Sciences Center.

 

Paul Buck, Chief Financial Officer

Prior to his appointment as the company's Chief Financial Officer, Mr. Buck had been working with CNS Response as an independent consultant since December 2008, assisting management with the company's finance and accounting functions. Prior to joining CNS Response, Mr. Buck worked as an independent consultant since 2004 and has broad experience with a wide variety of public companies. His projects include forensic accounting, restatements, acquisitions, interim management and system implementations. Mr. Buck, a Swiss National, was raised in Southern Africa and holds a Bachelor of Science degree in Chemistry and a Bachelor of Commerce degree both from the University of Cape Town, South Africa. He started his career with Touche Ross & Co. in Cape Town and qualified as a Chartered Accountant. In 1985, Mr. Buck joined the Los Angeles office of Touche Ross & Co. where he was an audit manager. In 1991, he joined the American Red Cross Biomedical Services as the CFO of the Southern California Region. After five years with the organization, he returned to Deloitte & Touche as a manager in the Solutions Consulting Group. In 1998, Mr. Buck was recruited back to the American Red Cross Biomedical Services as CFO and became the Director of Operations for the Southern California Region until 2003.

 

Brian MacDonald, Chief Technology Officer

Prior to receiving his MBA from Wharton in 1990, Brian MacDonald was trained in operations and chemical engineering. He consulted for Deloitte & Touche Management Consulting, KPMG Strategic Services and in private practice. His focus throughout this time was in the area of operations and information systems. He is co-founder of Mill City Venture Development that consulted for the predecessor company to CNS Response. In addition to his work in organizing operations, Mr. MacDonald has led the development of the rEEG® automated statistical report generator and the CNS Response managed care economic simulation and analysis software.

 

Michael Darkoch, Executive Vice President and Chief Marketing Officer

Michael Darkoch brings over 30 years of business development and executive management experience in the healthcare and pharmaceutical distribution field. In his role as Executive Vice President and Chief Marketing Officer for CNS Response, Mr. Darkoch will be responsible for managing and implementing various business activities associated with the launch and commercialization of rEEG. Prior to CNS Response, Mr. Darkoch’s career in healthcare began at Baxter International where he progressed through product development, logistics and distribution, business development and general manager over several business units. He pioneered business initiatives into home infusion, hospital systems, and alternate site delivery systems. He was responsible for client acquisition and renewal on the original Baxter team that developed Mail Order prescription fulfillment. This business unit was eventually spun-off and became Caremark Rx. Mr. Darkoch managed Caremark Rx sales and client growth from $100 million to $2.1 billion in a five-year timeframe. During that same timeframe he achieved an industry record of 98% client retention two years in a row. Mr. Darkoch left Caremark Rx in the late 1990's and managed business development and client management for two disability management companies-- CORE, Inc. and WorkWell Systems. In 2004, he reentered the PBM industry by joining MedImpact Health Systems in San Diego.  He managed new business development for self-insured clients achieving 25% growth per year; product development, releasing 2 major products in one year; and Specialty Pharmacy, a value added product generating $20 million in year one. Mr. Darkoch started his engineering and management career with Texas Instruments and Mobil Chemical Company. Mr. Darkoch holds a Bachelor of Science in Industrial Engineering from Lehigh University and Master of Science in Business from Southern Methodist University.

 


  

> Leadership

> Board of Directors

 
 
Copyright 2012 CNS Response